Report Overview:
Oligonucleotide synthesis is the chemicalsynthesis of relatively short fragments of nucleic acids with defined chemical structure (sequence). The technique is extremely useful in current laboratory practice because it provides a rapid and inexpensive access to custom-madeoligonucleotides of the desired sequence.
This report provides a deep insight into the global Oligonucleotide Synthesis Services market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, SWOT analysis, value chain analysis, etc.
The analysis helps the reader to shape the competition within the industries and strategies for the competitive environment to enhance the potential profit. Furthermore, it provides a simple framework for evaluating and accessing the position of the business organization. The report structure also focuses on the competitive landscape of the Global Oligonucleotide Synthesis Services Market, this report introduces in detail the market share, market performance, product situation, operation situation, etc. of the main players, which helps the readers in the industry to identify the main competitors and deeply understand the competition pattern of the market.
Market Value:
The global Oligonucleotide Synthesis Services market size was estimated at USD 814 million in 2024 and is projected to reach USD 1357.32 million by 2032, exhibiting a CAGR of 6.60% during the forecast period.
North America Oligonucleotide Synthesis Services market size was estimated at USD 236.78 million in 2024, at a CAGR of 5.66% during the forecast period of 2025 through 2032.
CAGR of 6.60% (2025 – 2032)
By Types:
• Intermediate-scale Synthesis Oligos
• Large-scale Synthesis Oligos
By Applications: Commercial
Academic Research
Key players include:
•Genescript
•GeneArt (Thermofischer)
•Renesas Electronics Corporation
•DNA 2.0 (ATUM)
•OriGene
•BBI
•Genewiz
•Eurofins Genomics
•Including or Excluding key companies relevant to your analysis.
